Biosimilar Avastin Is Launched In India
Cadila Pharmaceuticals Announces Entry
Outlining plans to launch “multiple biosimilar products this year for the Indian market,” Cadila Pharmaceutical has just rolled out a biosimilar to Avastin (bevacizumab) in its domestic market.
